TrialHuman vaccines2011
Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years.
Robert Arnou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
TrialHuman vaccines2011
Robert Arnou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.